Clinical Trial Update: Inflammation Following Mepolizumab and Oral Corticosteroids in Asthma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update assessing inflammation after mepolizumab and oral corticosteroids in asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Asthma | Phase 4 | Status: COMPLETED